chronic obstructive pulmonary disease	coexists with	bronchiectasis
bronchiectasis	coexists with	chronic obstructive pulmonary disease
chronic obstructive pulmonary disease	associated with	bronchiectasis
bronchiectasis	associated with	chronic obstructive pulmonary disease
bronchiectasis	common comorbidity of	chronic obstructive pulmonary disease
chronic obstructive pulmonary disease	common comorbidity of	bronchiectasis
bronchiectasis	predisposes to	chronic infection
chronic obstructive pulmonary disease	predisposes to	acute infection
bronchiectasis	predisposes to	pseudomonas colonization
bronchiectasis	predisposes to	mucus hypersecretion
bronchiectasis	diagnosed by	ct scan
ct scan	used for	bronchiectasis
spirometry	used for	chronic obstructive pulmonary disease
spirometry	measures	fev1
fev1	reflects	COPD severity
chronic obstructive pulmonary disease	diagnosed by	spirometry
bronchodilators	used for	chronic obstructive pulmonary disease
bronchodilators	relieve	dyspnea
inhaled corticosteroids	used for	chronic obstructive pulmonary disease
macrolide therapy	reduce	COPD exacerbations
airway clearance therapy	recommended for	bronchiectasis
airway clearance therapy	improves	sputum clearance
pulmonary rehabilitation	improves	exercise capacity
oxygen therapy	indicated for	hypoxemia
long-term oxygen therapy	indicated for	COPD with hypoxemia
long-term oxygen therapy	improves	survival
antibiotics	treat	respiratory infections
inhaled antibiotics	used for	bronchiectasis with chronic infection
pseudomonas infection	common in	bronchiectasis
bronchiectasis	colonized by	pseudomonas aeruginosa
pseudomonas aeruginosa	colonization in	bronchiectasis
chronic obstructive pulmonary disease exacerbations	escalate to	hospitalization
bronchiectasis	worsen	COPD outcomes
chronic obstructive pulmonary disease	worsen	bronchiectasis outcomes
acute exacerbation	common in	chronic obstructive pulmonary disease with bronchiectasis
bronchiectasis	increases	sputum production
chronic obstructive pulmonary disease	increases	sputum production
sputum production	indicates	infection
pneumonia	risk increases	COPD
respiratory infections	common in	chronic obstructive pulmonary disease
airway inflammation	present in	chronic obstructive pulmonary disease
airway inflammation	present in	bronchiectasis
immune deficiency	risk factor for	bronchiectasis
smoking	risk factor for	chronic obstructive pulmonary disease
smoking	worsens	chronic obstructive pulmonary disease symptoms
air pollution	risk factor for	chronic obstructive pulmonary disease
age	associated with	COPD progression
age	associated with	bronchiectasis progression
vaccination	recommended for	chronic obstructive pulmonary disease
influenza vaccination	recommended for	bronchiectasis
pneumococcal vaccination	recommended for	chronic obstructive pulmonary disease
bronchiolitis obliterans	related to	bronchiectasis
cor pulmonale	associated with	chronic obstructive pulmonary disease
pulmonary hypertension	associated with	chronic obstructive pulmonary disease
quality of life	reduced by	chronic obstructive pulmonary disease
quality of life	reduced by	bronchiectasis
healthcare utilization	higher in	chronic obstructive pulmonary disease with bronchiectasis
mortality	higher in	chronic obstructive pulmonary disease with bronchiectasis
readmission	higher risk in	chronic obstructive pulmonary disease with bronchiectasis
readmission	associated with	chronic obstructive pulmonary disease exacerbations
clinical phenotype	includes	chronic obstructive pulmonary disease with bronchiectasis
phenotype	influences	treatment decisions
treatment plan	tailored to	chronic obstructive pulmonary disease with bronchiectasis
clinical trial	evaluates	chronic obstructive pulmonary disease with bronchiectasis therapy
data	used for	predicting readmission in chronic obstructive pulmonary disease with bronchiectasis
outcome	predicted by	pulmonary rehabilitation
outcome	predicted by	antibiotic therapy
adherence	influences	chronic obstructive pulmonary disease management
economic burden	higher in	chronic obstructive pulmonary disease with bronchiectasis
healthcare utilization	higher in	chronic obstructive pulmonary disease with bronchiectasis
dyspnea	worsens	chronic obstructive pulmonary disease
dyspnea	worsens	bronchiectasis
exacerbation	triggers	hospitalization
airway hyperresponsiveness	present in	chronic obstructive pulmonary disease
lung hyperinflation	present in	chronic obstructive pulmonary disease
mucus hypersecretion	present in	chronic obstructive pulmonary disease
mucus hypersecretion	present in	bronchiectasis
chronic cough	present in	bronchiectasis
chronic cough	present in	chronic obstructive pulmonary disease
infection	triggers	chronic obstructive pulmonary disease exacerbations
infection	triggers	bronchiectasis exacerbations
treatment strategy	tailored to	chronic obstructive pulmonary disease with bronchiectasis
clinical guidelines	recommend	chronic obstructive pulmonary disease with bronchiectasis management
spirometry	monitors	disease progression
ct imaging	used for	diagnosing bronchiectasis in COPD
hrct	used for	diagnosing bronchiectasis in COPD
exercise capacity	improves with	pulmonary rehabilitation
body mass index	affects	COPD outcomes
nutritional status	affects	COPD management
lung function	improves with	bronchodilators
lung function	monitored by	spirometry
chronic obstructive pulmonary disease	is associated with	bronchiectasis
smoking	increases	COPD risk
air pollution	increases	COPD risk
age	increases	COPD risk
alpha-1 antitrypsin deficiency	increases	COPD risk
bronchiectasis	increases	COPD exacerbations
bronchiectasis	worsens	COPD outcomes
bronchiectasis	coexists with	COPD
Pseudomonas aeruginosa	colonizes	bronchiectasis
Haemophilus influenzae	colonizes	bronchiectasis
bronchiectasis	predisposes to	Pseudomonas colonization
bronchiectasis	predisposes to	chronic sputum production
COPD	treated with	bronchodilators
inhaled corticosteroids	increase	pneumonia risk
bronchodilators	relieve	dyspnea
oxygen therapy	indicated for	hypoxemia
pulmonary rehabilitation	improves	exercise tolerance
influenza vaccination	reduces	COPD exacerbations
pneumococcal vaccination	reduces	pneumonia risk
cor pulmonale	accompanies	COPD
pulmonary hypertension	accompanies	COPD
right heart failure	results from	pulmonary hypertension
emphysema	coexists with	bronchiectasis
bronchial wall thickening	accompanies	bronchiectasis
tree-in-bud	appears in	bronchiectasis
signet ring sign	indicates	bronchiectasis
high-resolution CT	diagnoses	bronchiectasis
bronchiectasis	diagnosed by	high-resolution CT
spirometry	diagnoses	COPD
FEV1	predicts	COPD mortality
FEV1	declines with	COPD progression
lung function	declines with	COPD progression
hyperinflation	is evident in	COPD
air trapping	is seen in	COPD
mucus plugging	contributes to	airway obstruction
neutrophilic inflammation	characterizes	bronchiectasis
neutrophil elastase	contributes to	airway damage
cystic fibrosis	causes	bronchiectasis
primary ciliary dyskinesia	causes	bronchiectasis
bronchodilator therapy	improves	exercise tolerance
LAMA	improves	lung function
LABA	improves	dyspnea
ICS	increases	pneumonia risk
antibiotics	treat	COPD exacerbations
macrolide therapy	reduces	COPD exacerbations
macrolide therapy	reduces	bronchiectasis exacerbations
aztreonam	is an	inhaled antibiotic
inhaled antibiotics	target	Pseudomonas infection in bronchiectasis
airway clearance therapy	improves	sputum clearance
lung secretions	accumulate in	bronchiectasis
oxygen therapy	improves	survival in COPD with hypoxemia
pseudomonas colonization	worsens	bronchiectasis prognosis
bronchiectasis severity	predicts	hospitalization risk
bronchiectasis management with	airway clearance therapy
chronic cough	presents in	COPD
sputum production	present in	chronic bronchitis
bronchitis	overlaps with	COPD
weight loss	worsens	COPD prognosis
anemia	worsens	COPD prognosis
cardiovascular disease	increases	COPD mortality
sleep apnea	coexists with	COPD
diabetes mellitus	complicates	COPD management
osteoporosis	accompanies	COPD
lung cancer	increases	COPD mortality
pulmonary rehabilitation	reduces	hospitalization risk
exercise training	reduces	COPD hospitalizations
blood oxygen saturation	decreases in	COPD exacerbations
home oxygen	reduces	hospitalization risk
telemonitoring	reduces	COPD readmissions
systemic inflammation	correlates with	COPD severity
CRP	correlates with	COPD exacerbation risk
procalcitonin	guides	antibiotic therapy in COPD exacerbations
airway remodeling	underlying	COPD pathophysiology
oxidative stress	drives	COPD progression
mucus hypersecretion	contributes to	airway obstruction
bronchiectasis management with	airway clearance therapy
respiratory infections	trigger	COPD exacerbations
bacterial infections	trigger	COPD exacerbations
viral infections	trigger	COPD exacerbations
significant infection	increases	COPD mortality
significant inflammation	reflects	COPD activity
beta-agonist therapy	used for	symptom relief
environmental tobacco smoke	worsens	COPD progression
lung function testing	monitors	COPD progression
bronchoscopy	used for	mucus clearance in bronchiectasis
COVID-19 infection	worsens	COPD outcomes
systemic corticosteroids	used for	COPD exacerbations
antibiotic stewardship	supports	COPD management
clinical guidelines	inform	COPD management
bronchiectasis	increases	sputum volume
sputum volume	predicts	bronchiectasis severity
microbiome	modulates	bronchiectasis progression
gas exchange abnormality	characterizes	COPD
hypoxemia	indicates	disease severity
morbidity	increases	bronchiectasis
morbidity	increases	COPD
hospital admission	reflects	COPD severity
lung hyperinflation	worsens	dyspnea
oxygen desaturation	occurs during	COPD exacerbations
treatment adherence	influences	COPD outcomes
